Effects of SB202190 on expression levels of IL-6 and NF-κB in flap ischemia-reperfusion injury

The aim of the current study was to investigate the effect of SB202190, a specific inhibitor of p38 MAPK signaling pathway, on the expression levels of IL-6 and NF-κB in flap ischemia-reperfusion injury. Healthy Sprague-Dawley rats were randomly divided into four groups of 12 each. For the ischemia-...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Kai, Ma, Jingxin, Liang, Wenyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122530/
https://www.ncbi.nlm.nih.gov/pubmed/30210603
http://dx.doi.org/10.3892/etm.2018.6442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122530/
https://www.ncbi.nlm.nih.gov/pubmed/30210603
http://dx.doi.org/10.3892/etm.2018.6442

Ejemplares similares